FIELD: medicine.
SUBSTANCE: system is applicable to skin surface.
EFFECT: improved flexibility and wear resistance.
7 cl, 3 dwg, 5 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| TRANSDERMAL THERAPEUTIC SYSTEM WITH HIGH LEVEL OF USING ACTIVE SUBSTANCE AND DOSE ACCURACY | 2007 |
|
RU2454994C2 |
| TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING LAVAND OIL | 2015 |
|
RU2695785C2 |
| HIGHLY PURE 3,3-DIPHENYLPROPYLAMINO MONOESTERS | 2004 |
|
RU2394019C2 |
| THERMOFUSIBLE TTS FOR APPLYING ROTIGOTIN | 2003 |
|
RU2304434C2 |
| TRANSDERMAL ADMINISTRATION OF MEMANTINE | 2011 |
|
RU2578971C2 |
| DEVICE FOR TRANSDERMAL INTRODUCTION OF ROTIGOTINE IN ORGANISM IN FORM OF BASE | 2003 |
|
RU2340339C2 |
| ESTRADIOL-CONTAINING TRANSDERMAL THERAPEUTIC SYSTEM | 1994 |
|
RU2140784C1 |
| TRANSDERMAL THERAPEUTIC SYSTEM FOR VOLATILE AND/OR THERMOLABILE SUBSTANCES | 2006 |
|
RU2434631C2 |
| TOLTERODIN-CONTAINING TRANSDERMAL THERAPEUTIC SYSTEM (TTS) | 2000 |
|
RU2251413C2 |
| SELF-DEGRADABLE TRANSDERMAL THERAPEUTIC SYSTEM WITH IMPROVED FUNCTIONAL PARAMETERS AND EFFICACY | 2009 |
|
RU2506948C2 |
